Eton Pharma rises as FDA accepts methanol poisoning drug application
** Shares of drug developer Eton Pharmaceuticals ETON.O
rise 11.3% to $3.66
** U.S. FDA accepts co's application to approve its
experimental dehydrated alcohol injection to treat methanol
poisoning
** The health regulator will finalize its decision for the
drug on June 27 - ETON
** ETON fell ~23.5% in the past 12 months
(Reporting by Mariam E Sunny)
((Mariam.ESunny@thomsonreuters.com;))
Recent news on Eton Pharmaceuticals
See all newsBrief: Eton Pharmaceuticals Under Agreement, Co Pays Aquestive Upfront License Fee Of $10 Million - SEC Filing
Aquestive rises on US licensing deal for seizure drug with Eton Pharma
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer